BioXcel Therapeutics Investor Relations Material
Latest events
Q3 2024
BioXcel Therapeutics
Q1 2025
12 May, 2025
Q4 2024
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BioXcel Therapeutics Inc
Access all reports
BioXcel Therapeutics, Inc. is a biopharmaceutical company focused on utilizing artificial intelligence to discover and develop new therapies in neuroscience and immuno-oncology. The company leverages its proprietary AI platform to identify and advance drug candidates for the treatment of complex conditions, including psychiatric disorders and cancers. BioXcel Therapeutics is engaged in both clinical and preclinical development. The company is headquartered in New Haven, United States, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
BTAI
Country
🇺🇸 United States